AME Logo

O_19: Influences on Pharmacokinetics of ledipasvir, sofosbuvir and GS-331007 in patients with decompensated cirrhosis – results from the UK Expanded Access programme- Omar Elsherif

Slideset

Loading PDF…

Page 1 of 1